In mantle cell lymphoma (MCL), an incurable subtype of non-Hodgkin lymphoma, SPEN was found to be one of the genes with the highest mutational frequency difference from baseline samples (samples taken at the time of diagnosis) to samples taken at more advanced stages of the disease, suggesting its potential role in disease progression [67]. Here, SPEN is linked to non-Hodgkin lymphoma.